Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Tramontin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Iscience|October 26, 2020
Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino AcidsMichael J Hamill, Raffi Afeyan, Manu V Chakravarthy, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Clinical and Translational Gastroenterology|September 21, 2020
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B CirrhosisManu V Chakravarthy, Joel Neutel, Scharmen Confer, et al.
Nature Reviews. Drug Discovery|October 10, 2009
The future of drug development: advancing clinical trial designJohn Orloff, Frank Douglas, Jose Pinheiro, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Iscience|October 26, 2020
Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino AcidsMichael J Hamill, Raffi Afeyan, Manu V Chakravarthy, et al.
Scientific Reports|June 5, 2021
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell modelsNadine Daou, Andreu Viader, Murat Cokol, et al.
Clinical and Translational Gastroenterology|September 21, 2020
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B CirrhosisManu V Chakravarthy, Joel Neutel, Scharmen Confer, et al.
Nature Reviews. Drug Discovery|October 10, 2009
The future of drug development: advancing clinical trial designJohn Orloff, Frank Douglas, Jose Pinheiro, et al.
Pageof 1